Poleganov MA - Search Results

1

Trans-amplifying RNA expressing functional miRNA mediates target gene suppression and simultaneous transgene expression.

Yıldız A, Hasani A, Hempel T, Köhl N, Beicht A, Becker R, Hubich-Rau S, Suchan M, Poleganov MA, Sahin U, Beissert T. Yıldız A, et al. Among authors: poleganov ma. Mol Ther Nucleic Acids. 2024 Mar 5;35(2):102162. doi: 10.1016/j.omtn.2024.102162. eCollection 2024 Jun 11. Mol Ther Nucleic Acids. 2024. PMID: 38545619 Free PMC article.

2

Improving mRNA-Based Therapeutic Gene Delivery by Expression-Augmenting 3' UTRs Identified by Cellular Library Screening.

Orlandini von Niessen AG, Poleganov MA, Rechner C, Plaschke A, Kranz LM, Fesser S, Diken M, Löwer M, Vallazza B, Beissert T, Bukur V, Kuhn AN, Türeci Ö, Sahin U. Orlandini von Niessen AG, et al. Among authors: poleganov ma. Mol Ther. 2019 Apr 10;27(4):824-836. doi: 10.1016/j.ymthe.2018.12.011. Epub 2018 Dec 18. Mol Ther. 2019. PMID: 30638957 Free PMC article.

3

Efficient Reprogramming of Human Fibroblasts and Blood-Derived Endothelial Progenitor Cells Using Nonmodified RNA for Reprogramming and Immune Evasion.

Poleganov MA, Eminli S, Beissert T, Herz S, Moon JI, Goldmann J, Beyer A, Heck R, Burkhart I, Barea Roldan D, Türeci Ö, Yi K, Hamilton B, Sahin U. Poleganov MA, et al. Hum Gene Ther. 2015 Nov;26(11):751-66. doi: 10.1089/hum.2015.045. Epub 2015 Oct 1. Hum Gene Ther. 2015. PMID: 26381596

4

Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond.

Vallazza B, Petri S, Poleganov MA, Eberle F, Kuhn AN, Sahin U. Vallazza B, et al. Among authors: poleganov ma. Wiley Interdiscip Rev RNA. 2015 Sep-Oct;6(5):471-99. doi: 10.1002/wrna.1288. Epub 2015 Jun 9. Wiley Interdiscip Rev RNA. 2015. PMID: 26061157 Review.

5

Genome-wide analysis displays marked induction of EBI3/IL-27B in IL-18-activated AML-derived KG1 cells: critical role of two kappaB binding sites in the human EBI3 promotor.

Poleganov MA, Bachmann M, Pfeilschifter J, Mühl H. Poleganov MA, et al. Mol Immunol. 2008 May;45(10):2869-80. doi: 10.1016/j.molimm.2008.01.021. Epub 2008 Mar 11. Mol Immunol. 2008. PMID: 18336908

6

Expanding extracellular zinc beyond levels reflecting the albumin-bound plasma zinc pool potentiates the capability of IL-1beta, IL-18, and IL-12 to Act as IFN-gamma-inducing factors on PBMC.

Poleganov MA, Pfeilschifter J, Mühl H. Poleganov MA, et al. J Interferon Cytokine Res. 2007 Dec;27(12):997-1001. doi: 10.1089/jir.2007.0037. J Interferon Cytokine Res. 2007. PMID: 18184040

7

Interleukin-18 directly activates T-bet expression and function via p38 mitogen-activated protein kinase and nuclear factor-kappaB in acute myeloid leukemia-derived predendritic KG-1 cells.

Bachmann M, Dragoi C, Poleganov MA, Pfeilschifter J, Mühl H. Bachmann M, et al. Among authors: poleganov ma. Mol Cancer Ther. 2007 Feb;6(2):723-31. doi: 10.1158/1535-7163.MCT-06-0505. Mol Cancer Ther. 2007. PMID: 17308068

8

Interleukin-18 secretion and Th1-like cytokine responses in human peripheral blood mononuclear cells under the influence of the toll-like receptor-5 ligand flagellin.

Bachmann M, Horn K, Poleganov MA, Paulukat J, Nold M, Pfeilschifter J, Mühl H. Bachmann M, et al. Among authors: poleganov ma. Cell Microbiol. 2006 Feb;8(2):289-300. doi: 10.1111/j.1462-5822.2005.00621.x. Cell Microbiol. 2006. PMID: 16441439

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8 results

Search Page